Clinical Trials Directory

Trials / Unknown

UnknownNCT03583112

Investigation of the Changes of Brain Structure and Function in Premature Ejaculation Patients and the Effects of Dapoxetine on Central Neural Activity in Premature Ejaculation Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Xidian University · Academic / Other
Sex
Male
Age
18 Years – 64 Years
Healthy volunteers
Accepted

Summary

Lifelong premature ejaculation (LPE) is a common male sexual dysfunction with a high prevalence in global. Up to now, the etiology of LPE remains unclear. In recent years, dapoxetine, a highly potent serotonin-transporter inhibitor, has been used for treating premature ejaculation. However, the underlying mechanism of dapoxetine was unknown. Recently, with widespread use of neuroimaging techniques, like positron emission tomography and magnetic resonance imaging (MRI) in basic science, researchers can acquire human data on cerebral base of human sexual behavior, not only in normal subjects but also in patients with sexual dysfunction. Therefore, in order to further understand the biological mechanism of LPE and the brain targets of dapoxetine, the present study would investigate the brain changes of LPE and the effect of dapoxetine on brain activation by using MRI technology.

Conditions

Interventions

TypeNameDescription
DRUGDapoxetine Hydrochloride Tabletoral one dapoxetine hydrochloride tablet before MRI scan
DRUGPlacebo Tabletoral one placebo tablet before MRI scan.

Timeline

Start date
2018-07-10
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2018-07-11
Last updated
2018-08-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03583112. Inclusion in this directory is not an endorsement.